Covid-19: Oxford-AstraZeneca vaccine approval 'moment of pride'

The Oxford-AstraZeneca vaccine approval is "a real moment of pride" for the team behind it, says Prof Andrew Pollard, director of the Oxford Vaccine Group.

The UK has ordered 100 million doses vaccine, enough for 50 million people, with rollout beginning on 4 January.

30 December 2020